Connection

Timothy Caradonna to Spike Glycoprotein, Coronavirus

Back to Details
This is a "connection" page, showing publications Timothy Caradonna has written about Spike Glycoprotein, Coronavirus.
Timothy Caradonna
Connection Strength
0.121
Spike Glycoprotein, Coronavirus
  1. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell. 2021 08 05; 184(16):4203-4219.e32.
    View in: PubMed
    Score: 0.026
  2. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. Sci Immunol. 2020 10 08; 5(52).
    View in: PubMed
    Score: 0.025
  3. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2. Cell. 2020 11 12; 183(4):1043-1057.e15.
    View in: PubMed
    Score: 0.025
  4. Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters. Nat Med. 2020 11; 26(11):1694-1700.
    View in: PubMed
    Score: 0.025
  5. Rapid generation of potent antibodies by autonomous hypermutation in yeast. Nat Chem Biol. 2021 10; 17(10):1057-1064.
    View in: PubMed
    Score: 0.007
  6. COVID-19-neutralizing antibodies predict disease severity and survival. Cell. 2021 01 21; 184(2):476-488.e11.
    View in: PubMed
    Score: 0.006
  7. Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic. JAMA Netw Open. 2020 12 01; 3(12):e2030455.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.